Tis the season for sickness in South Florida."I see him very congestion, very gloomy," said Jamie Jorge, of Coral ...

The American Academy of Pediatrics has issued updated recommendations for RSV prevention in infants and high-risk young children.

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective ...

As an FDA official said that the agency has evidence that links COVID vaccines to the deaths of at least 10 children, the U.S ...

Respiratory syncytial virus infection in adults aged 45 years or older is significantly associated with a higher 1-year risk ...

In this morning's Pharmalittle roundup, we're reading about FDA scrutiny of RSV therapies, an AI tool for clinical trials, ...

Among adults older adults, a respiratory syncytial virus (RSV) infection increases the risk of cardiovascular events over the ...

Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

Respiratory syncytial virus, commonly known as RSV, is often associated with cold-like symptoms in young children.

The FDA reportedly told drugmakers that approved monoclonal antibodies to protect infants against respiratory syncytial virus ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

Vaccination of pregnant women against respiratory syncytial virus is linked to a substantial reduction in infants' risk for ...